Overview of the Renewal

The Renewal of the National Cervical Screening Program aims to ensure the continuing success of the Program so that all Australian women, vaccinated and unvaccinated have access to a cervical screening program based on current evidence and best practice.

Page last updated: 01 March 2017

Implementation of the renewed National Cervical Screening Program

The Renewal of the National Cervical Screening Program will be implemented on 1 December 2017.

Until the renewed National Cervical Screening Program is implemented, our world-class cervical cancer screening program will continue. It is important that women continue to have Pap smears every two years and talk to their doctor or health care professional if they have any questions.

Read more about the Future changes to the National Cervical Screening Program and the National Cervical Screening Program implementation date .

The Renewal is a strategy for reviewing the policy and operation of the National Cervical Screening Program (NCSP) .

The aim of the Renewal is to ensure the continuing success of the National Cervical Screening Program so that all Australian women, vaccinated and unvaccinated, have access to a cervical screening program based on current evidence and best practice.

Overseeing the Renewal

The Standing Committee on Screening (SCoS), a sub-committee of the Australian Health Ministers’ Advisory Council (AHMAC), is overseeing the Renewal. The SCoS is a committee with representatives from the Commonwealth, state and territory governments.

There are a number of committees with members who are clinical experts guiding the process of introducing the new Cervical Screening Test.

Regular updates on the Renewal are provided to a Partner Reference Group (PRG) that is open to all stakeholders including industry, Health Care Professionals, peak organisations and other interested parties. Join the PRG by emailing the Cervical Renewal team.

Endorsement of the Renewal

Prior to recommending the new cervical screening pathway, the Medical Services Advisory Committee (MSAC) assessed an extensive review of available clinical evidence and modelling of potential screening pathways.

The Interim Renewal Implementation Plan was endorsed by AHMAC in September 2014 and a draft renewed policy was approved in-principle by AHMAC in March 2015.

The Australian Government's commitment as part of the 2015-16 Commonwealth budget provided funding for the renewal.

The Australian and state and territory governments will continue to work together to ensure the successful implementation of the renewed National Cervical Screening Program.

Changes to the Medicare Benefits Schedule (MBS) require consideration by the Australian Government. Other changes to the National Cervical Screening Program, including registry functions, are for consideration by the Australian Health Ministers’ Advisory Council (AHMAC).

Read more about what the future changes to the National Cervical Screening Program mean for women from 1 December 2017.

In this section